Effects of nosocomial candidemia on outcomes of critically Ill patients

American Journal of Medicine

Volumn 113, Issue 6, 2002, Pages 480-485

  Blot, Stijn I ^a   Vandewoude, Koenraad H ^a   Hoste, Eric A ^a   Colardyn, Francis A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA; CANDIDIASIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FUNGEMIA; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SENESCENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; APACHE; CANDIDIASIS; CASE-CONTROL STUDIES; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; FUNGEMIA; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0037109554     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01248-2     Document Type: Article

References (28)

1. Flanagan P.G., Barnes R.A. Fungal infection in the intensive care unit. J Hosp Infect. 38:1998;163-177.
2. Jarvis W.R., Martone W.J. Predominant pathogens in hospital infections. J Antimicrob Chemother. 29:(suppl A):1992;19-24.
3. Vincent J.L., Bihari D.J., Suter P.M., Bruining H., et al. The prevalence of nosocomial infection in intensive care units in Europe (EPIC). JAMA. 274:1995;639-644.
4. Vincent J.L., Anaissie E., Bruining H., et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intens Care Med. 24:1998;206-216.
5. Wenzel R.P. Nosocomial candidemia risk factors and attributable mortality. Clin Infect Dis. 20:1995;1531-1534.
6. Wey S.B., Motomi M., Pfaller M., et al. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 148:1988;2642-2645.
7. Cornwell E.E., Belzberg H., Offne T.V., et al. The pattern of fungal infections in critically ill surgical patients. Am Surg. 61:1995;847-850.
8. Slotman G.J., Shapiro E., Moffa S.M. Fungal sepsis multisite colonization versus fungemia. Am Surg. 60:1994;107-113.
9. Nolla-Salas J., Sitges-Serra A., Leon-Gil C., et al. Candidemia in non-neutropenic critically ill patients analysis of prognostic factors and assessment of systemic antifungal therapy. Intens Care Med. 23:1997;23-30.
10. Eubanks P.J., de Virgilio C., Klein S., Bongard F. Candida sepsis in surgical patients. Am J Surg. 166:1993;617-619.
11. Voss A., le Noble J.L., Verduyn-Lunel F.M., et al. Candidemia in intensive care unit patients risk factors for mortality. Infection. 10:1997;10-13.
12. Ekenna O., Sherertz R.J., Bingham H. Natural history of blood stream infections in burn patient population the importance of candidemia. Am J Infect Control. 21:1993;189-195.
13. Blot S., Vandewoude K., Hoste E., et al. Outcome in critically ill patients with candidal fungaemia Candida albicans vs Candida glabrata. J Hosp Infect. 47:2001;308-313.
14. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II a severity of disease classification system. Crit Care Med. 13:1985;818-829.
15. Rello J., Ochagavia A., Sabanes E., et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med. 162:2000;1027-1030.
16. Girou E., Stephan F., Novara A., et al. Risk factors and outcome of nosocomial infections results of a matched case-control study of ICU patients . Am J Respir Crit Care Med. 157:1998;1151-1158.
17. Rello J., Jupert P., Valles J., et al. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis. 23:1996;973-978.
18. Blot S., Vandewoude K., Hoste E., Colardyn F. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 162:2002;2229-2235.
19. Wenzel R.P. The mortality of hospital-acquired blood stream infections need for a new vital statistic? Int J Epidemiol. 17:1988;225-227.
20. DiGiovine B., Chenoweth C., Watts C., Higgins M. The attributable mortality and costs of primary nosocomial blood stream infections in the intensive care unit. Am J Respir Crit Care Med. 160:1999;976-981.
21. Haley R. Measuring the costs of nosocomial infections methods for estimating economic burden for the hospital . Am J Med. 91:(suppl 3B):1991;32S-38S.
22. Pittet D., Monod M., Suter P.M., et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 220:1994;751-758.
23. Solomkin J.S., Flohr A.B., Simmons R.L. Indications for therapy for fungemia in postoperative patients. Arch Surg. 117:1982;1272-1275.
24. Fraser V.J., Jones M., Dunkel J., et al. Candidemia in a tertiary care hospital epidemiology, risk factors, andpredictors of mortality . Clin Infect Dis. 15:1992;414-421.
25. Pelz R., Hendrix C., Swoboda S., et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 233:2001;542-548.
26. Rex J.H., Bennet J.E., Sugar A.M., et al. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis. 21:1995;994-996.
27. Ngyuen M.H., Peacock J.E., Tanner D.C., et al. Therapeutic approaches in patients with candidemia. Arch Intern Med. 155:1995;2429-2435.
28. Nucci M., Colombo A.L., Silveira F., et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol. 19:1998;846-850.